Serafini Steven, O'Flaherty Cristian
Department of Medicine, Experimental Medicine Division, McGill University, Montréal, Québec, Canada; Department of Surgery, Urology Division, McGill University, Montréal, Québec, Canada; The Research Institute, McGill University Health Centre, Montréal, Québec, Canada.
Department of Medicine, Experimental Medicine Division, McGill University, Montréal, Québec, Canada; Department of Surgery, Urology Division, McGill University, Montréal, Québec, Canada; The Research Institute, McGill University Health Centre, Montréal, Québec, Canada; Department of Anatomy and Cell Biology, McGill University, Montréal, Québec, Canada; Department of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada.
Redox Biol. 2025 Jul;84:103669. doi: 10.1016/j.redox.2025.103669. Epub 2025 May 15.
Infertility is a significant public health concern, affecting one in six couples globally, with male-factor infertility representing half of all cases. Obesity is an important health problem and is increasingly linked to poor reproductive outcomes as it induces metabolic disturbances and dyslipidemia, both of which impair male fertility. Dyslipidemia, characterized by abnormal lipid profiles, is associated with declining sperm quality and alters cholesterol and sphingolipid abundances in the seminal plasma. Sperm capacitation enables spermatozoa to acquire fertilizing competence by promoting cholesterol efflux from the plasma membrane, modifying lipid composition and membrane fluidity, and enhancing the ability to recognize and fertilize the oocyte. However, the intricate interplay between cholesterol efflux and capacitation-associated modifications in human spermatozoa remains poorly understood. Sphingolipids, including Ceramide (Cer) and sphingosine-1-phosphate (S1P), are critical regulators of cellular functions that play a significant role in male reproductive health. These bioactive lipids and cholesterol promote sperm capacitation, motility, and the acrosome reaction (AR). We hypothesize that dysregulated lipid homeostasis, as seen in cases of dyslipidemia, can impair capacitation by disrupting lipid-signalling pathways and promoting oxidative stress. Our results demonstrate that methyl-β-cyclodextrin (MβCD), which extracts cholesterol from the sperm plasma membrane, enhances a variety of capacitation-associated adaptations, including tyrosine phosphorylation, hyperactive motility, and AR. Moreover, sphingolipid signalling, through the S1PR1/3 receptors, is crucial in mediating these effects. MβCD-cholesterol extraction is also associated with nitric oxide (NO) and superoxide (O) production, key signalling molecules involved in capacitation. However, dysregulated lipid metabolism, characterized by elevated cholesterol sulfate (Chol-SO), Cer, and Sphingosine (Sph), impairs sperm capacitation through excessive oxidative stress and promotes oxidative damage. The findings suggest that disruptions in lipid metabolism resulting from conditions like obesity can interfere with sperm capacitation and fertilizing potential, providing new insights into male infertility mechanisms.
不孕不育是一个重大的公共卫生问题,全球每六对夫妇中就有一对受其影响,其中男性因素导致的不孕不育占所有病例的一半。肥胖是一个重要的健康问题,并且越来越多地与不良生殖结果相关联,因为它会引发代谢紊乱和血脂异常,这两者都会损害男性生育能力。血脂异常以脂质谱异常为特征,与精子质量下降有关,并会改变精浆中的胆固醇和鞘脂丰度。精子获能通过促进胆固醇从质膜流出、改变脂质组成和膜流动性以及增强识别和使卵母细胞受精的能力,使精子获得受精能力。然而,人类精子中胆固醇流出与获能相关修饰之间的复杂相互作用仍知之甚少。鞘脂,包括神经酰胺(Cer)和鞘氨醇-1-磷酸(S1P),是细胞功能的关键调节因子,在男性生殖健康中发挥重要作用。这些生物活性脂质和胆固醇促进精子获能、运动和顶体反应(AR)。我们假设,如在血脂异常病例中所见,脂质稳态失调会通过破坏脂质信号通路和促进氧化应激来损害获能。我们的结果表明,从精子质膜中提取胆固醇的甲基-β-环糊精(MβCD)可增强多种与获能相关的适应性变化,包括酪氨酸磷酸化、过度活跃的运动和顶体反应。此外,通过S1PR1/3受体的鞘脂信号传导对于介导这些作用至关重要。MβCD-胆固醇提取还与一氧化氮(NO)和超氧化物(O)的产生有关,这是参与获能的关键信号分子。然而,以硫酸胆固醇(Chol-SO)、神经酰胺和鞘氨醇(Sph)升高为特征的脂质代谢失调会通过过度氧化应激损害精子获能并促进氧化损伤。研究结果表明,肥胖等状况导致的脂质代谢紊乱会干扰精子获能和受精潜力,为男性不育机制提供了新的见解。